Alkermes Plc (ALKS)
44.44
+0.81
(+1.86%)
USD |
NASDAQ |
Oct 26, 16:00
44.78
+0.34
(+0.77%)
After-Hours: 05:04
Alkermes Price to Book Value : 4.117 for Oct. 26, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 26, 2026 | 4.117 |
| October 23, 2026 | 4.042 |
| October 22, 2026 | 4.093 |
| October 21, 2026 | 4.028 |
| October 20, 2026 | 4.086 |
| October 19, 2026 | 3.981 |
| October 16, 2026 | 3.819 |
| October 15, 2026 | 3.715 |
| October 14, 2026 | 3.620 |
| October 13, 2026 | 3.680 |
| October 12, 2026 | 3.730 |
| October 09, 2026 | 3.762 |
| October 08, 2026 | 3.716 |
| October 07, 2026 | 3.839 |
| October 06, 2026 | 3.858 |
| October 05, 2026 | 3.961 |
| October 02, 2026 | 3.868 |
| October 01, 2026 | 3.756 |
| September 30, 2026 | 3.754 |
| September 29, 2026 | 3.780 |
| September 28, 2026 | 3.719 |
| September 25, 2026 | 3.784 |
| September 24, 2026 | 3.779 |
| September 23, 2026 | 3.903 |
| September 22, 2026 | 4.010 |
| Date | Value |
|---|---|
| September 21, 2026 | 4.093 |
| September 18, 2026 | 4.020 |
| September 17, 2026 | 4.327 |
| September 16, 2026 | 4.268 |
| September 15, 2026 | 4.264 |
| September 14, 2026 | 4.246 |
| September 11, 2026 | 4.259 |
| September 10, 2026 | 4.272 |
| September 09, 2026 | 4.206 |
| September 08, 2026 | 4.214 |
| September 04, 2026 | 4.271 |
| September 03, 2026 | 4.343 |
| September 02, 2026 | 4.421 |
| September 01, 2026 | 4.372 |
| August 31, 2026 | 4.353 |
| August 28, 2026 | 4.392 |
| August 27, 2026 | 4.53 |
| August 26, 2026 | 4.554 |
| August 25, 2026 | 4.559 |
| August 24, 2026 | 4.527 |
| August 21, 2026 | 4.477 |
| August 20, 2026 | 4.448 |
| August 19, 2026 | 4.649 |
| August 18, 2026 | 4.584 |
| August 17, 2026 | 4.618 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amarin Corp. Plc | 0.5724 |
| Prothena Corp. Plc | 1.515 |
| Incyte Corp. | 3.589 |
| Cue Biopharma, Inc. | 41.77 |
| ADC Therapeutics SA | -- |
Price to Book Value Related Metrics
| PE Ratio | 115.43 |
| PS Ratio | 4.515 |
| Price to Free Cash Flow | 33.97 |
| Price | 44.44 |
| Earnings Yield | 0.87% |
| Market Cap | 7.446B |
| Operating PE Ratio | 52.41 |
| Normalized PE Ratio | 90.40 |